blind randomized

Related by string. * Bed Liner . BLIND . BLIN . Blind : blind placebo controlled . blind eye . Blind Faith . Blind Side / Randomized . randomizing . randomizer : randomized controlled trial . randomized controlled trials . randomized placebo controlled . randomized clinical trials * blind randomized placebo . blind randomized controlled . Double Blind Randomized . blind randomized multicenter *

Related by context. Frequent words. (Click for all words.) 85 blind randomized placebo 80 randomized placebo controlled 78 placebo controlled 77 double blind placebo 76 prospective randomized 76 randomized double 75 randomized controlled 75 blind placebo controlled 74 randomized 73 multicenter 70 randomized clinical 66 randomized controlled trial 66 Randomized 64 multicenter study 63 dose escalation study 60 Phase 2b study 60 prospective cohort 60 Phase IIb trial 60 pivotal Phase III 60 mg BID 59 dose escalation 59 Phase 2b 59 Phase IIb 59 Phase Ib 59 Phase 2b clinical 59 pharmacodynamics 58 observational study 58 randomized clinical trials 58 Phase III clinical 58 Phase IIa 58 randomized Phase 58 clinical trial 57 multiple ascending dose 57 pivotal Phase 57 dose regimen 57 Phase 2b trial 57 Phase 2a clinical 57 Phase III 57 Phase 1b 56 unblinded 56 non inferiority 56 randomized controlled trials 56 Phase III pivotal 56 tolerability 56 randomized trials 56 plus ribavirin 55 monotherapy 55 Phase IIa trial 55 mg dose 55 Phase IIb clinical 55 safety tolerability 55 dosing regimens 55 post hoc 54 rosuvastatin 54 Phase 2a 54 n = 53 ACTEMRA 53 pharmacokinetics 53 RG# [001] 53 relapsing remitting multiple sclerosis 53 Phase IIa clinical 53 adalimumab 53 randomly assigned 53 investigational oral 53 FOLFOX 52 telmisartan 52 pharmacokinetic 52 evaluable patients 52 Phase III trials 52 TMC# [001] 52 placebo 52 JANUVIA 52 lubiprostone 52 citalopram 52 primary endpoint 51 mg/m2 51 allopurinol 51 meta analysis 51 pegylated interferon 51 ticagrelor 51 sunitinib 51 dosing 51 aliskiren 50 mg doses 50 CYPHER R Stent 50 gemcitabine 50 sitagliptin 50 tiotropium 50 demonstrated statistically significant 50 temozolomide 50 pharmacokinetic profile 50 SEROQUEL 50 REBETOL 50 VELCADE 49 Phase III clinical trials 49 etanercept 49 amlodipine 49 primary efficacy endpoint 49 bevacizumab 49 hypertensive patients 49 clopidogrel

Back to home page